Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Stemtech (STEK) EBIT Margin (2020 - 2025)

Historic EBIT Margin for Stemtech (STEK) over the last 6 years, with Q3 2025 value amounting to 39.8%.

  • Stemtech's EBIT Margin rose 296500.0% to 39.8% in Q3 2025 from the same period last year, while for Sep 2025 it was 48.55%, marking a year-over-year increase of 268400.0%. This contributed to the annual value of 47.22% for FY2024, which is 386200.0% up from last year.
  • Per Stemtech's latest filing, its EBIT Margin stood at 39.8% for Q3 2025, which was up 296500.0% from 43.13% recorded in Q2 2025.
  • In the past 5 years, Stemtech's EBIT Margin registered a high of 2.52% during Q4 2024, and its lowest value of 323.05% during Q3 2022.
  • Its 5-year average for EBIT Margin is 79.05%, with a median of 69.45% in 2024.
  • Its EBIT Margin has fluctuated over the past 5 years, first crashed by -2420100bps in 2022, then skyrocketed by 2784500bps in 2023.
  • Quarter analysis of 5 years shows Stemtech's EBIT Margin stood at 138.76% in 2021, then surged by 71bps to 40.04% in 2022, then crashed by -162bps to 104.79% in 2023, then surged by 102bps to 2.52% in 2024, then plummeted by -1677bps to 39.8% in 2025.
  • Its last three reported values are 39.8% in Q3 2025, 43.13% for Q2 2025, and 138.81% during Q1 2025.